Page last updated: 2024-09-03

1-ethyl-3-(3-dimethylaminoethyl)carbodiimide and arginine vasopressin

1-ethyl-3-(3-dimethylaminoethyl)carbodiimide has been researched along with arginine vasopressin in 1 studies

Compound Research Comparison

Studies
(1-ethyl-3-(3-dimethylaminoethyl)carbodiimide)
Trials
(1-ethyl-3-(3-dimethylaminoethyl)carbodiimide)
Recent Studies (post-2010)
(1-ethyl-3-(3-dimethylaminoethyl)carbodiimide)
Studies
(arginine vasopressin)
Trials
(arginine vasopressin)
Recent Studies (post-2010) (arginine vasopressin)
6801012,2784221,212

Protein Interaction Comparison

ProteinTaxonomy1-ethyl-3-(3-dimethylaminoethyl)carbodiimide (IC50)arginine vasopressin (IC50)
Vasopressin V2 receptorHomo sapiens (human)0.242

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Davies, AR; Wheatley, M1

Other Studies

1 other study(ies) available for 1-ethyl-3-(3-dimethylaminoethyl)carbodiimide and arginine vasopressin

ArticleYear
The importance of acidic amino acid residues in the binding of ligands to the V1a vasopressin receptor.
    Biochemical Society transactions, 1995, Volume: 23, Issue:1

    Topics: Animals; Arginine Vasopressin; Binding Sites; Carbodiimides; Cell Membrane; Dicyclohexylcarbodiimide; Kinetics; Ligands; Liver; Protein Binding; Rats; Receptors, Vasopressin

1995